Pharmaceuticals

Drug Development Biotechnology Acquisitions Drug Pricing Manufacturing Drug Manufacturing Vaccine Development Corporate Governance Mergers and Acquisitions Companies

George Tidmarsh Takes Helm at FDA Biologics Center, Stoking Independence Concerns

His ascent signals a shift toward pro-industry decisions that critics say undermine scientific rigor at the FDA.

GSK Closes $12 Billion Licensing Pact for Hengrui’s COPD Therapy and 11 Preclinical Assets

AstraZeneca H1 Revenue Jumps 11% as It Pledges $50 Billion U.S. Expansion

Bristol Myers and Bain Capital Launch $300 Million Immunology Spinout

EU Regulator Recommends AstraZeneca’s Low-Carbon COPD Inhaler

State Department Proposes Major Cut to PEPFAR Despite Congressional Reprieve

AstraZeneca Commits $50 Billion to U.S. Manufacturing and Research by 2030

Chinese Court Sentences Astellas Pharma Executive to 3½ Years as Japanese Firms Tighten China Protocols

WHO Endorses Twice-Yearly Lenacapavir Injections for HIV Prevention

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy

House Judiciary Committee Subpoenas Pfizer Scientist Over 2020 Vaccine Timing Allegations

Merck Completes €3 Billion Springworks Deal in Largest Pharma Acquisition Since 2007

Torrent to Acquire Controlling Stake in JB Pharma in ₹25,689 Crore Deal

Moderna’s mRNA-1010 Flu Vaccine Outperforms Standard Shot and Advances Toward Approval

Alembic Pharma Secures USFDA Approval for Liposomal Doxorubicin ANDA

Study Finds 88% of AI Health Responses False as One-Third Would Consult AI Doctors

IIT Kanpur and IISc to Launch On-Campus Medical Schools in India’s Health-Tech Drive

Senator Maggie Hassan Launches Probe of GSK’s Pediatric Asthma Inhaler Switch

ED Seizes Vehicles, Bank Assets and Liquor in Probe of ADC Nishant Sareen

GSK and Bharat Biotech to Cut Malaria Vaccine Price Below $5 by 2028